Review in Polymers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Elena O BakhrushinaDepartment of Pharmaceutical Technology, A.P. Nelyubin Institute of Pharmacy, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Trubetskaya Street 8-2, Moscow 119991, Russia.ORCID 0000-0001-8695-0346
Victor S PyzhovDepartment of Pharmaceutical Technology, A.P. Nelyubin Institute of Pharmacy, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Trubetskaya Street 8-2, Moscow 119991, Russia.ORCID 0000-0003-2174-7157
Jana A YuntunenDepartment of Pharmaceutical Technology, A.P. Nelyubin Institute of Pharmacy, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Trubetskaya Street 8-2, Moscow 119991, Russia.
Alexander S GulenkovAll-Russian Scientific Research Institute of Medicinal and Aromatic Plants, Federal State Scientific Institution, Grina Street 7, Moscow 117216, Russia.ORCID 0000-0002-1532-9330
Shoyad D ArislanovN.V. Sklifosovskiy Institute of Clinical Medicine, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Trubetskaya Street 8-2, Moscow 119991, Russia.ORCID 0000-0002-7744-705X
Ksenia V EremeevaN.V. Sklifosovskiy Institute of Clinical Medicine, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Trubetskaya Street 8-2, Moscow 119991, Russia.ORCID 0000-0001-7071-2415
Anastasiya V BelyatskayaDepartment of Pharmaceutical Technology, A.P. Nelyubin Institute of Pharmacy, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Trubetskaya Street 8-2, Moscow 119991, Russia.
Natalia B DeminaDepartment of Pharmaceutical Technology, A.P. Nelyubin Institute of Pharmacy, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Trubetskaya Street 8-2, Moscow 119991, Russia.
Ivan I KrasnyukDepartment of Pharmaceutical Technology, A.P. Nelyubin Institute of Pharmacy, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Trubetskaya Street 8-2, Moscow 119991, Russia.ORCID 0000-0001-8557-8829
Ivan I KrasnyukDepartment of Pharmaceutical Technology, A.P. Nelyubin Institute of Pharmacy, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Trubetskaya Street 8-2, Moscow 119991, Russia.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Xyloglucan is a highly promising 'green' polymer that has found its application in the food and pharmaceutical industries. Due to its molecular structure similarity to mucin, it has remarkable mucoadhesion properties, which has led to a high research interest in this excipient for the development of transmucosal delivery systems. Thermosensitivity is another promising property of xyloglucan derivatives, which is mainly exhibited by synthetic block copolymers such as pluronics and PLGA derivatives. Delivery systems whose mechanism of active ingredient release is based on temperature sensitivity are widely used in many medical fields, ranging from antitumour therapy to intranasal delivery. Thus, conducting research on the possibility of obtaining and using a new mucoadhesive, fully biocompatible and affordable polymer-xyloglucan-is a promising task.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Sources and Methods for the Production of Xyloglucan, a Promising Stimulus-Sensitive Biopolymer: A Review. · full record | OpenQuestion